CA - A Cancer Journal for Clinicians Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

CA: A Cancer Journal for Clinicians is a peer-reviewed journal published for the American Cancer Society by John Wiley & Sons, Inc. CA publishes comprehensive review articles of a multidisciplinary nature, which take into account the journal’s diverse readership of primary care physicians; medical, surgical, and radiation oncologists; nurses; and other health care and public health professionals. Articles published in CA provide up-to-date information on all aspects of cancer prevention, early detection, treatment of all forms, palliation, advocacy, quality of life, and more.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2500 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

CA - A Cancer Journal for Clinicians

88,192

SJR Impact factor

156

H Index

36

Total Docs (Last Year)

129

Total Docs (3 years)

2924

Total Refs

22644

Total Cites (3 years)

89

Citable Docs (3 years)

255,73

Cites/Doc (2 years)

81,22

Ref/Doc


Best articles

A guide to cancer of the ear

View more

A Technique for Localizing Occult Breast Lesions

View more

A Tribute to Charles S. Cameron, MD, CA's Founding Editor

View more

Acupressure and Acupuncture for Side Effects of Radiotherapy

View more

American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer

View more

American Cancer Society guidelines for the early detection of breast cancer: update 1997

View more

American Cancer Society guidelines on screening for breast cancer: An overview

View more

Bladder cancer, 1996

View more

Bladder cancer: state-of-the-art care

View more

Cancer and placebos

View more

Cancer chemotherapeutic agents

View more

Cancer chemotherapeutic and biologic agents

View more
SHOW MORE ARTICLES

Chemotherapy-related nausea and vomiting: To the editor

View more

Commentary on "European Consensus Statement on Lung Cancer"

View more

Consensus statement from the American Cancer Society Workshop on neuroblastoma screening: Do benifit from mass screening for neuroblastoma?

View more

Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence

View more

Editorial: Children and cancer

View more

Editorial: The environmental time bomb ...that never went off

View more

Electronic cigarettes did not help patients with cancer stop smoking

View more

Elimination of cancer disparities via organizational transformation and community-driven approaches

View more

Enhancing global access to cancer medicines

View more

Estrogens and increased endometrial cancer: Fact or artifact?

View more

Examining the hypopharynx

View more

Exemestane is effective for the chemoprevention of breast cancer

View more

Comments

No comments ... Be the first to comment!